Reversal agents

Andrew Sim, Angela Vick

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

One of the clinical indications for administering cholinesterase inhibitors, or anticholinesterases, is to reverse the effect of muscle relaxation by non-depolarizing neuromuscular blocking agents at the conclusion of surgery. The purpose of administering antimuscarinic drugs concomitantly with anticholinesterases is to minimize the muscarinic side effects associated with increased acetylcholine transmission at muscarinic receptors. In this chapter, we review anticholinesterase and anticholinergic pharmacology, including mechanism of action, dosing, and adverse effects. We discuss their clinical significance in both the surgical context and their indications outside the operating room. In addition, we briefly discuss the relaxant binding agent sugammadex and its future role in anesthesia.

Original languageEnglish (US)
Title of host publicationEssentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care
PublisherSpringer New York
Pages205-218
Number of pages14
ISBN (Print)9781461489481, 9781461489474
DOIs
StatePublished - Jan 1 2015

Fingerprint

Cholinesterase Inhibitors
Neuromuscular Blocking Agents
Muscarinic Antagonists
Muscle Relaxation
Cholinergic Antagonists
Muscarinic Receptors
Operating Rooms
Cholinergic Agents
Acetylcholine
Anesthesia
Pharmacology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sim, A., & Vick, A. (2015). Reversal agents. In Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care (pp. 205-218). Springer New York. https://doi.org/10.1007/978-1-4614-8948-1_13

Reversal agents. / Sim, Andrew; Vick, Angela.

Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, 2015. p. 205-218.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sim, A & Vick, A 2015, Reversal agents. in Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, pp. 205-218. https://doi.org/10.1007/978-1-4614-8948-1_13
Sim A, Vick A. Reversal agents. In Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York. 2015. p. 205-218 https://doi.org/10.1007/978-1-4614-8948-1_13
Sim, Andrew ; Vick, Angela. / Reversal agents. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, 2015. pp. 205-218
@inbook{437b5bc64180401d803982c118ddf556,
title = "Reversal agents",
abstract = "One of the clinical indications for administering cholinesterase inhibitors, or anticholinesterases, is to reverse the effect of muscle relaxation by non-depolarizing neuromuscular blocking agents at the conclusion of surgery. The purpose of administering antimuscarinic drugs concomitantly with anticholinesterases is to minimize the muscarinic side effects associated with increased acetylcholine transmission at muscarinic receptors. In this chapter, we review anticholinesterase and anticholinergic pharmacology, including mechanism of action, dosing, and adverse effects. We discuss their clinical significance in both the surgical context and their indications outside the operating room. In addition, we briefly discuss the relaxant binding agent sugammadex and its future role in anesthesia.",
author = "Andrew Sim and Angela Vick",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-8948-1_13",
language = "English (US)",
isbn = "9781461489481",
pages = "205--218",
booktitle = "Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care",
publisher = "Springer New York",

}

TY - CHAP

T1 - Reversal agents

AU - Sim, Andrew

AU - Vick, Angela

PY - 2015/1/1

Y1 - 2015/1/1

N2 - One of the clinical indications for administering cholinesterase inhibitors, or anticholinesterases, is to reverse the effect of muscle relaxation by non-depolarizing neuromuscular blocking agents at the conclusion of surgery. The purpose of administering antimuscarinic drugs concomitantly with anticholinesterases is to minimize the muscarinic side effects associated with increased acetylcholine transmission at muscarinic receptors. In this chapter, we review anticholinesterase and anticholinergic pharmacology, including mechanism of action, dosing, and adverse effects. We discuss their clinical significance in both the surgical context and their indications outside the operating room. In addition, we briefly discuss the relaxant binding agent sugammadex and its future role in anesthesia.

AB - One of the clinical indications for administering cholinesterase inhibitors, or anticholinesterases, is to reverse the effect of muscle relaxation by non-depolarizing neuromuscular blocking agents at the conclusion of surgery. The purpose of administering antimuscarinic drugs concomitantly with anticholinesterases is to minimize the muscarinic side effects associated with increased acetylcholine transmission at muscarinic receptors. In this chapter, we review anticholinesterase and anticholinergic pharmacology, including mechanism of action, dosing, and adverse effects. We discuss their clinical significance in both the surgical context and their indications outside the operating room. In addition, we briefly discuss the relaxant binding agent sugammadex and its future role in anesthesia.

UR - http://www.scopus.com/inward/record.url?scp=84944535082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944535082&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8948-1_13

DO - 10.1007/978-1-4614-8948-1_13

M3 - Chapter

AN - SCOPUS:84944535082

SN - 9781461489481

SN - 9781461489474

SP - 205

EP - 218

BT - Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care

PB - Springer New York

ER -